Purpose. To assess the loco-regional distribution pattern of a blue dye tracer, as a surrogate for a chemotherapeutic agent, injected in the invasion edge of resectable lung tumor; to evaluate the technique efficacy at staining the lung-tumor interface and the metastatic pathways. Methods. Between November 2014 and September 2015, we enrolled 33 patients (17 women, 16 men; 52-87 years old) presenting with 31 primary lung carcinomas and 2 metastases. We injected in vivo (n=17) or ex vivo (n=16) the innermost side of the tumor invasion edge with 1.3ml methylene blue dye. We performed the injection alone (n=12) or combined with a focal freezing (n=21). We assessed the stain distribution into the invasion-edge, the tumor, the lung or the node(s) at gross and microscopic examination. Results. At gross examination, we observed a quick, intense staining of the invasion edge, and a concomitant staining of the tumor and the lung. The staining pattern was heterogeneous in the tumor, homogeneous in the invasion edge and the lung irrespective of the focal freezing, tumor type, size, or blood perfusion status. The microscopic examination evidenced the staining of the matrix, vessel lumens, and tumor cells, except for lymph nodes. Conclusions. The inner side of the invasion edge looks a suitable location for directly injecting and distributing the methylene blue tracer within the interstitium and related draining pathways during the resection of primary or secondary lung tumor. Fresh resection specimens are convenient to evaluate new edge-targeting injections techniques for the diagnostic or therapeutic management of cell dissemination during surgery.
INTRODUCTION
The resection of the primary tumor and locoregional lymph nodes is the best curative option for stage I to IIIA NSCLC, but the rate of loco-regional and local plus distant recurrences after curative surgery, respectively 17% to 27% and 39% is high [1] . Adjuvant systemic chemotherapy (ACT) has demonstrated modest survival benefit largely confined to patients with stage II disease [2] .
----------------11]. Thus, the tumor interstitium has increasingly become a target for various diagnosis and therapeutic agents [12] .
The peritumoral (PT) and/or intratumoral (IT) injection of chemotherapeutic (CT) agents has emerged as a useful and efficacious method in controlling lung tumors [13, 14,] .
The advantages of local over systemic chemotherapy [CT] are an elevated local drug concentration, little or no side effects, and the modulation of local plus distant antitumor immunity [15] .
Whether the tumor approach is surgical, endoscopic or per-cutaneous, the gross tumor edge is the usual landmark for assessing the location of the injection needle (s), since it is a marker of the procedure realization and efficacy evaluation [16] . However, the spatial positioning of the needle is based on a rough estimate of the tumor edge, as exemplified with the high variability of results currently observed for lung cancer lymphatic mapping [17, 18] .
Chemoablation, a therapeutic method that injects cytotoxics directly in multiple IT and PT sites shows undeniable local cell kill efficacy [14, 19] . Still the procedure lacks a precise spatial reference for the peritumoral needle insertion and therefore remains very operator-dependent. In this translational study, we propose to use a readily locatable region of the tumor edge as a spatial reference for the injection (s); a tumor region that interfaces with the adjacent lung parenchyma and possesses similar interstitial fluid transport characteristics [20] .
We describe here the direct injection of a fixed dose of methylene blue dye (MB) in the innermost side of the tumor invasion edge (IE). MB is a small, weakly basic drug, a known localization-tracer for a lung tumor [21] , a photosensitizer [22] , and a lymphatic tracer [23] . This monoinstitutional study includes 33 human patients presenting with resectable stage I-IIIA primary (n=31) or metastatic tumors (n=2). The primary objective was to investigate the MB migration rate, direction and pattern within the tumor and the lung draining pathways. A secondary goal was to assess the seamless integration of the procedure within the workflow of conventional surgery. We evaluated various injection strategies, whether injection was the sole modality or a combination with a nearby focal tumor freezing, and whether the procedure took place during or after the surgical resection. Therefore, we could compare the tracer migration in perfused, in vivo, and non-perfused, ex vivo, lung-tumor samples. The simultaneous focal freezingand-injection aimed at evaluating whether the combined procedure would affect the dye migration pattern compared to the injection alone, as previously demonstrated in pre-clinical studies [24, 25] .
PURPOSES, SUBJECTS and METHODS:
2.1 Purposes. Our primary goal was to develop a reliable injection technique of the inner side of the invasion edge of resectable lung tumors.
We investigated at gross and microscopic examination the migration rate, direction and pattern of methylene blue (MB) within the tumor and the lung; we compared the staining results whether the injection was the sole modality or was associated with a nearby focal tumor freezing, and whether the procedure took place during or after the surgical resection. . Another goal was to assess the seamless integration of the procedure within the workflow of conventional surgery. The ultimate objective of our research is to use the knowledge gained from this study for the development of intraoperative, antimetastatic local drug delivery techniques during the surgery of lung tumors. Table 2 . 
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Given the limited number of cases and the qualitative aspect of the study, we did not conduct any statistical evaluation.
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RESULTS AND DISCUSSION
The staining rate, localization and pattern of methylene blue (MB) within the edge interface, the tumor and the lung exhibited large variations.
Staining rate and spread: The MB constantly stained the lung-tumor interface and migrated within tumor and the surrounding lung. At gross examination of the tumor cross sections the dye was spreading over 30% to 50% of the tumor perimeter for 27/33 (81%) cases, and over 50% of the perimeter for the rest. The stained area was grander, >50%, in the tumor core or in the contiguous lung, respectively for 7/33 (21%) and 6/33 (18%) procedures.
This intra-and extra-tumoral localization of the MB tracer was similar for the in vivo and ex vivo cases, regardless of the MB migration time; a time that was inevitably longer in vivo compared to ex vivo as shown in Table 2 . In all cases, the MB stained the cryoprobe site either during the thaw of after the full melting of the frozen tissue, but never during the freezing. during the needle removal, and the lost dose was not compensated for. In one case, a minor leakage of the dye occurred in the bronchial tree during a wedge resection.
The procedure was not associated with any side effects or intraoperative or postoperative adverse event. injection pressure and resulting pressure gradient created in the edge is the main driver of the drug flow. For Zhang [36] such flow commences at a 24mmHg infusion pressure threshold; over this threshold, the tumor interstitial fluid channels, usually poorly connected, would open and interconnect. We infer that the convergent flow of the tracer towards the tumor core is due to an injection pressure grander than the interstitial fluid pressure. In vivo the IFP is about 25mmHg in the tumor core, and is slightly positive or close to zero mmHg in the edge [12] ; ex vivo, in an integral tumor specimen [33] the IFP is also low, ~3mmHg.
DISCUSSION
The higher migration rate of the dye outwards in the lung, although not quantified, would have a similar ground. The low IFP in the edge-lung region would promote a higher migration spread of the dye, a trend seen in Table 3 The tumor edge delineation and the needle insertion were two crucial steps of the procedure. The gross margin was the beacon for the needle insertion, but sometimes it was not directly visible or palpable. The use of atraumatic Duval clamps helped with presenting the tumor edge to the needle; as did the cryoprobe, which could stuck to, lift and orientate the tumor, as described by others [38, 39] .
Overall, we estimated the spatial positioning of the needle to be within ± 3mm. In seven in vivo cases, the lung was injected due to an unwanted needle motion off target, and we had to reposition the needle; a fact that lead us to make a depth stop for that small needle diameter. Intraoperative ultrasound for the determination of the tumor edge and more precise needle guidance was not used, due to the likely prolongation of anesthesia and known limitations of ultrasound imaging in the lung [16] .
Despite our rough estimate of the exact needle tip location, the consistent patterns of edge staining observed in our study may indicate that the whole edge fluid space is a
proper target for an interstitial injection. However, the width of this interstitial fluid space is an estimate [28, 40] , and we could not assess a posteriori the exact location of the needle tip due to the rapid spread of the dye.
MB was selected as a surrogate for a chemotherapeutic agent that we could inject in similar conditions. MB is a weak basic drug that gets protonated in the acidic environment of the tumor edge [41] and therefore may disperse mostly in the interstitial fluid space of the edge, as it seems from our study. We anticipate that the chemotherapeutics doxorubicin, mitoxantrone, vincristine, and vinblastine, which are also protonated in acidic environment, and display a decreased cellular uptake [42] , would behave like the MB [43] . Additionally the MB tracer could serve as a co-marker of the distribution pattern for the above drugs, except mitoxantrone, a known chromophore.
We successfully demonstrated in an animal tumor model the freezing-assisted injection and distribution of MB combined with epirubicin, another weak basic cytotoxic, at the tumor edge; the cell kill was predominant at this stained area [24] . The outer edge is already the target of no-touch thermal or non-thermal tumor ablation techniques that aim at decreasing the intraoperative cell dissemination [44] . The third implication is a procedural confirmation that the ice margin must cover the whole tumor edge to prevent the co-injected dye from permeating the frozen tumor. However, the post thaw region behaves as a trap for the dye, and therefore a possible modulator of the drug pharmacokinetics during resection [24] . All the patients provided their informed consent before the procedure.
CONCLUSIONS
All data generated or analyzed during this study are included in this published article 
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